Merck & Co.'s Covid-19 pill is giving rise to new mutations of the virus in some patients, according to a study that underscores the risk of trying to intentionally alter the pathogen's genetic code. Some researchers worry the drug may create more contagious or health-threatening variations of Covid.
Merck's drug, Lagevrio, has been found in dozens of patients
- The drug-linked mutations of the virus haven't been shown to be more immune-evasive or lethal yet, but their very existence highlights potential risks in wider use of the drug, which was recently cleared in China.
Merck disputes the view that its drug is causing problematic variants
- "There is no evidence to indicate that any antiviral agent has contributed to the emergence of circulating variants," Merck spokesman Robert Josephson said in an email in response to questions about the study.
- The US Food and Drug Administration, which authorized Lagevrio in late 2021, said it doesn't comment on third-party research.
https://sharylattkisson.com/2023/02/study-mercks-covid-drug-linked-to-new-virus-mutations/
No comments:
Post a Comment